Giorgio Sirugo Selected Research

Giorgio Sirugo Research Topics

Disease

9	Infections 01/2020 - 03/2008
7	Malaria 01/2020 - 05/2006
6	Tuberculosis (Tuberculoses) 06/2017 - 10/2003
6	Pulmonary Tuberculosis 01/2017 - 04/2004
3	COVID-19 01/2022 - 01/2021
3	Inflammation (Inflammations) 01/2020 - 05/2006
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2017 - 01/2012
3	Glucosephosphate Dehydrogenase Deficiency 01/2017 - 05/2006
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2016 - 10/2014
2	Iron Deficiencies 01/2020 - 11/2008
2	HIV Infections (HIV Infection) 06/2017 - 07/2009
2	Anemia 07/2009 - 11/2008
1	Heart Failure 12/2019
1	Cardiomyopathies (Cardiomyopathy) 12/2019
1	Ototoxicity 10/2015
1	Hearing Loss (Hearing Impairment) 10/2014
1	Atherosclerosis 06/2013
1	Pseudomonas Infections 11/2012
1	Cystic Fibrosis (Mucoviscidosis) 11/2012
1	Lung Diseases (Lung Disease) 11/2012
1	Critical Illness (Critically Ill) 01/2012
1	Trachoma 06/2010
1	Sickle Cell Trait 06/2010
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 11/2008
1	Disease Susceptibility (Diathesis) 07/2008
1	Hepatitis B 03/2008
1	Hemolysis 05/2006
1	Stillbirth 07/2004
1	Meningococcal Meningitis 11/2003

Drug/Important Bio-Agent (IBA)

5	IronIBA 01/2020 - 05/2006
3	Amikacin (A.M.K)FDA LinkGeneric 10/2016 - 10/2014
3	AminoglycosidesIBA 10/2016 - 10/2014
3	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 05/2006
3	Proteins (Proteins, Gene)FDA Link 06/2013 - 01/2012
3	VaccinesIBA 08/2010 - 03/2008
3	HaptoglobinsIBA 06/2010 - 05/2006
2	Angiotensin-Converting Enzyme 2IBA 01/2022 - 01/2022
2	CytokinesIBA 06/2017 - 03/2016
2	EnzymesIBA 01/2017 - 01/2012
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2017 - 05/2014
2	glucose-6-phosphate dehydrogenase A-IBA 05/2014 - 07/2004
1	AntigensIBA 01/2022
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	InterferonsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Prealbumin (Transthyretin)IBA 12/2019
1	Amyloid (Amyloid Fibrils)IBA 12/2019
1	Tuberculin (PPD)IBA 06/2017
1	Interleukin-9 (Interleukin 9)IBA 06/2017
1	QuartzIBA 01/2017
1	MetalloporphyrinsIBA 01/2017
1	Interleukin-12 (IL 12)IBA 03/2016
1	antineoplaston A10 (A 10)IBA 10/2015
1	oxidized low density lipoproteinIBA 06/2013
1	Scavenger Receptors (Scavenger Receptor)IBA 04/2013
1	LipidsIBA 04/2013
1	PTX3 proteinIBA 11/2012
1	Pattern Recognition ReceptorsIBA 11/2012
1	Heme Oxygenase-1IBA 01/2012
1	Heme (Haem)IBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	Interleukin-12 Subunit p40IBA 02/2011
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2011
1	dapsone drug combination chloroguanilIBA 01/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2010
1	Lymphotoxin-alpha (Lymphotoxin)IBA 11/2008
1	Peptides (Polypeptides)IBA 11/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2008
1	Cathepsin ZIBA 07/2008
1	Type 3 Melanocortin ReceptorIBA 07/2008
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2008
1	Oxidants (Oxidizing Agents)IBA 01/2008
1	Glucose-6-PhosphateIBA 05/2006
1	Blood Proteins (Serum Proteins)IBA 05/2006
1	zinc protoporphyrinIBA 05/2006
1	PolymersIBA 05/2006
1	Transferrin (beta 2 Transferrin)IBA 05/2006
1	Ferritins (Ferritin)IBA 05/2006
1	Transferrin Receptors (Transferrin Receptor)IBA 05/2006
1	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2004
1	Interleukin-8 (Interleukin 8)IBA 04/2004
1	Toll-Like Receptor 4IBA 11/2003
1	CD40 Ligand (CD40L)IBA 10/2003

Therapy/Procedure

3	Therapeutics 03/2016 - 07/2008
2	Duration of Therapy 10/2015 - 10/2014
1	Electronic Nose 01/2017